Crow, TJ, MacMillan, JF, Johnson, AL, Johnstone, EC. A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry
1986; 148: 120–7.
Loebel, AD, Lieberman, JA, Alvir, JM, Mayerhoff, DI, Geisler, SH, Szymanski, SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry
1992; 149: 1183–8.
Szymanski, S, Lieberman, JA, Alvir, JM, Mayerhoff, D, Loebel, A, Geisler, S, Chakos, M, Koreen, A, Jody, D, Kane, JM. Gender differences in onset of illness, treatment response, course and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry
1995; 152: 698–703.
Larsen, TK, McGlashan, TH, Moe, LC. First-episode schizophrenia: I. Early course parameters. Schizophr Bull
1996; 2: 241–56.
Bottlender, R, Strauss, A, Moller, HJ. Impact of duration of symptoms prior to first hospitalisation on acute outcome in 998 schizophrenic patients. Schizophr Res
2000; 44: 145–50.
Malla, AK, Norman, RMG, Manchanda, R, Ahmed, MR, Scholten, D, Harricharan, R, Cortese, L, Takhar, J. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res
2002; 54: 231–42.
Harrigan, SM, McGorry, PD, Krstev, H. Does treatment delay in first-episode psychosis really matter?
2003; 33: 97–110.
Addington, J, van Mastrigt, S, Addington, D. Duration of untreated psychosis: impact on untreated 2-year outcome. Psychol Med
2004; 34: 277–84.
Wunderink, A, Nienhuis, FJ, Sytema, S, Wiersma, D. Treatment delay and response rate in first-episode psychosis. Acta Psychiatr Scand
2006; 113: 332–9.
Craig, TJ, Bromet, EJ, Fennig, S, Tanenberg-Karant, M, Lavelle, J, Galambos, N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?
Am J Psychiatry
2000; 157: 60–6.
Ho, BC, Andreasen, NC, Flaum, M, Nopoulos, P, Miller, D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry
2000; 157: 808–15.
Verdoux, H, Liraud, F, Bergey, C, Assens, F, Abalan, F, van Os, J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophr Res
2001; 49: 231–41.
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry
2005; 62: 975–83.
Perkins, DO, Gu, H, Boteva, K, Lieberman, JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia. Am J Psychiatry
2005; 162: 1785–804.
Rund, BR, Melle, I, Friis, S, Larsen, TK, Midbøe, LJ, Opjordsmoen, S, Simonsen, E, Vaglum, P, McGlashan, T. Neurocognitive dysfunction in first episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry
2004; 161: 466–72.
Breier, A, Schreiber, JL, Dyer, J, Pickar, D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry
1991; 48: 239–46.
Smith, TE, Hull, JW, Goodman, M, Hedayat-Harris, A, Willson, D, Israel, L, Munich, RL. The relative influences of symptoms, insight and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis
1999; 187: 102–8.
Green, MF. What are the functional consequences of neurocognitive deficits in schizophrenia?
Am J Psychiatry
1996; 153: 321–30.
Barnes, TRE, Hutton, SB, Chapman, MJ, Mutsatsa, S, Puri, BK, Joyce, EM. West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry
2000; 177: 207–11.
Hutton, SB, Puri, BK, Duncan, LJ, Robbins, TW, Barnes, TRE, Joyce, EM. Executive function in first-episode schizophrenia. Psychol Med
1998; 28: 463–73.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) . APA, 1994.
Andreasen, N. Methods for assessing positive and negative symptoms. Mod Probl Pharmacopsychiatry
1990; 24: 73–88.
Liddle, PF, Barnes, TR. Syndromes of chronic schizophrenia. Br J Psychiatry
1990; 157: 558–61.
Gur, RE, Petty, RG, Turetsky, BI, Gur, RC. Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophr Res
1996; 21: 1–12.
Liddle, PF. The symptoms of chronic schizophrenia: a re-examination of the positive–negative dichotomy. Br J Psychiatry
1987; 151: 145–51.
Möller, HJ, van Praag, HM, Aufdembrinke, B, Bailey, P, Barnes, TRE, Beck, J, Bentsen, H, Eich, FX, Farrow, L, Fleischhacker, WW, Gerlach, J, Grafford, K, Heutschel, B, Hertkorn, A, Heylen, S, Lecrubier, Y, Leonard, JP, McKenna, P, Maier, W, Pedersen, V, Rappard, A, Rein, W, Ryan, J, Nielsen, MS, Stieglitz, R-D, Wegener, G, Wilson, J. Negative symptoms in schizophrenia: considerations for clinical trials. Psychopharmacology
1994; 115: 221–8.
Nelson, HE. National Adult Reading Test (NART), Second Version: Test Manual. nferNelson, 1991.
Wechsler, D. The Wechsler Adult Intelligence Scale – Revised Manual. Psychological Corporation, 1981.
Sahakian, BJ, Owen, AM. Computerised assessment in neuropsychiatry using CANTAB: discussion paper. J Roy Soc Med
1992; 85: 399–402.
Birchwood, M, Smith, J, Cochrane, R, Wetton, S. Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry
1990; 157: 853–9.
Perkins, DO, Lieberman, JA, Gu, H, Tohen, M, McEvoy, J, Green, AI, Zipursky, RB, Strakowski, SM, Sharma, T, Kahn, RS, Gur, R, Tollefson, G, for the HGDH Research Group. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry
2004; 185: 18–24.
Barnes, TRE, Liddle, PF. Evidence for the validity of negative symptoms. Mod Probl Pharmacopsychiatry
1990; 24: 43–72.
Üçok, A, Polat, A, Genç, A, Cakir, S, Turan, N. Duration of untreated psychosis may predict acute treatment response in first-episode schizophrenia. J Psychiatr Res
2004; 38: 163–8.
Drake, RJ, Haley, CJ, Akhtar, S, Lewis, SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry
2000; 177: 511–5.
Kalla, O, Aaltonen, J, Wahlstrom, J, Lehtinen, V, Garcia Cabeza, I, Gonzalez de Chavez, M. Duration of untreated psychosis and its correlates in first episode psychosis in Finland and Spain. Acta Psychiatr Scand
2002; 106: 265–75.
McGorry, PD, Edwards, J, Mihalopolous, C, Harrigan, SM, Jackson, HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull
1996; 22: 305–26.
Oosthuizen, P, Emsley, RA, Keyter, N, Niehaus, DJH, Koen, L. Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country. Acta Psychiatr Scand
2005; 111: 214–9.
Malla, AK, Norman, RMG, Takhar, J, Townsend, L, Scholten, D, Haricharan, R. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis?
J Nerv Ment Dis
2004; 192: 455–63.
Larsen, TK, Moe, LC, Vibe-Hansen, L, Johannessen, JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res
2000; 45: 1–9.
Schmitz, N, Malla, A, Norman, R, Archie, S, Zipursky, R. Inconsistency in the relationship between duration of untreated psychosis (DUP) and negative symptoms: sorting out the problem of heterogeneity. Schizophr Res
2007; 93: 152–9.
Edwards, J, Harrigan, SM, McGorry, PD, Amminger, GP. Duration of untreated psychosis (DUP) and outcome in schizophrenia. Psychol Med
2002; 32: 563–4.
Norman, RMG, Lewis, SW, Marshall, M. Duration of untreated psychosis and its relationship to clinical outcome. Br J Psychiatry
2005; 187 (suppl 48): s519–23.
Peralta, V, Cuesta, MJ. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr Res
1999; 38: 13–26.
Joyce, E, Hutton, S, Mutsatsa, S, Gibbins, H, Webb, E, Paul, S, Robbins, T, Barnes, TRE. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry
2002; 181 (suppl 43): s38–44.
Hoff, AL, Sakuma, M, Heydebrand, G, Heydebrand, G, Csernansky, JG, DeLisi, LE. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry
2000; 157: 1824–8.
Norman, RMG, Townsend, L, Malla, AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry
2001; 179: 340–5.
Ho, BC, Alicata, D, Ward, J, Moser, DJ, O'Leary, DS, Arndt, S, Andreasen, NC. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry
2003; 160: 142–8.
Joyce, EM, Hutton, SB, Mutsatsa, SH, Barnes, TRE. Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatry
2005; 187: 516–22.
Wyatt, RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull
1991; 17: 325–51.
Keshavan, MS, Haas, GL, Kahn, CE, Aguilar, E, Dick, EL, Schooler, NR, Sweeney, JA, Pettegrew, JW. Superior temporal gyrus and the course of early schizophrenia: progressive, static or reversible?
J Psychiatry Res
1998; 32: 161–7.
Lappin, JM, Morgan, K, Morgan, C, Hutchison, G, Chitnis, X, Suckling, J, Fearon, P, McGuire, PK, Jones, PB, Leff, J, Murray, RM, Dazzan, P. Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res
2006; 83: 145–53.
DeLisi, LE, Sakuma, M, Tew, W, Kushner, M, Hoff, AL, Grimson, R. Schizophrenia as a chronic active brain process: a study of progressive brain structural changes subsequent to the onset of schizophrenia. Psychiatr Res
1997; 74: 129–40.
Keefe, RS, Seidman, LJ, Christensen, BK, Hamer, RM, Sharma, T, Sitskoorn, MM, Lewine, RRJ, Yurgelun-Todd, DA, Gur, RC, Tohen, M, Tollefson, GD, Sanger, TM, Lieberman, JA. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first episode psychosis: a randomised double blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry
2004; 161: 985–95.
Addington, J, Saeedi, H, Addington, D. Influence of social perception and social knowledge on cognitive and social functioning in early psychosis. Br J Psychiatry
2006; 189: 373–8.
Brekke, JS, Hoe, M, Long, J, Green, MF. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophr Bull
2007; 33: 1247–56.